Tender detail

Oral anti-infective medicines

Summary

Ida-Viru Central Hospital Foundation is procuring oral anti-infective medicines for 24 months in 14 lots. The lots cover tablets or capsules containing amoxicillin/clavulanic acid (875 mg/125 mg and 500 mg/125 mg), cefuroxime (500 mg), sulfamethoxazole/trimethoprim (800 mg/160 mg), clarithromycin (500 mg), azithromycin (500 mg), clindamycin (300 mg), ciprofloxacin (500 mg), metronidazole (500 mg), fluconazole (150 mg), aciclovir (400 mg), nitrofurantoin (50 mg), valaciclovir (500 mg) and oseltamivir (75 mg).

Reference number
306802-0000
Buyer
Sihtasutus Ida-Viru Keskhaigla
Country
Estonia (EST)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2026-10-27
Status
Open
Contract subject
Supplies
Estimated value
27 600,00 EUR
Source
RHR

Participation requirements

Tender requirements are available in the official tender documents.

Compliance requirements

The bidder must declare whether it, or anyone in its management, supervisory bodies or authorised representatives, has relevant final convictions within the past five years or remains subject to an exclusion period for participation in a criminal organisation, corruption, fraud, terrorist offences, money laundering or terrorist financing, child labour or human trafficking. Declarations also cover breaches of tax or social security payment obligations; bankruptcy, insolvency, liquidation or similar circumstances; creditor arrangements; suspended business activities; serious professional misconduct; competition-distorting agreements; conflicts of interest that cannot otherwise be avoided; involvement in preparing this procurement where it creates an unavoidable competitive advantage; and serious or repeated breaches of previous contracts resulting in early termination, damages, price reductions or penalties. Exclusion grounds also include breaches of environmental, social or labour-law obligations; false or misleading statements, omission of required information or failure to provide requested supporting documents; attempts to improperly influence the contracting authority or obtain confidential information; enabling unlawful employment of a foreign national; being subject to an international sanction; and relevant tax-related criminal convictions. For tax debts in Estonia, the notice states that a certificate is not issued where the debt, excluding interest not determined by an administrative act, is below EUR 100 or payment has been deferred. Where legally permitted, the bidder may provide evidence of measures taken to restore its reliability.

Qualification criteria and exclusion grounds

For all 14 lots, the bidder must hold a medicinal products wholesale authorisation issued by the Estonian State Agency of Medicines; the contracting authority will verify it in the agency’s register. The offered medicines must have a marketing authorisation issued by the State Agency of Medicines, or an import or use permit issued by the agency. The bidder must provide descriptions and manufacturer’s information or other materials that allow the contracting authority to assess compliance with the tender documents. Where equivalence is offered, it must be explained and supported by evidence; other relevant evidence may be accepted where the bidder demonstrates compliance with the stated requirements. The bid must include the participation application (Form 1) and completed price offer (Form 4). A power of attorney (Form 2) is required if the signatory is not listed as authorised to represent the legal entity in the register. Joint bidders must appoint an authorised representative and include their power of attorney. Conditional bids are not permitted. The bidder must identify and justify any information claimed as a trade secret; bid prices and price components may not be designated as trade secrets. No specific award criterion is stated in the provided documents.